Anzeige
Mehr »
Mittwoch, 13.05.2026 - Börsentäglich über 12.000 News
Bahnbrechende KI-Lösung "Ohne Nadelstiche" als Ersatz für herkömmliche Bluttests "unlocked"?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0MS6X | ISIN: US6024961012 | Ticker-Symbol: N/A
NASDAQ
13.05.26 | 21:59
3,535 US-Dollar
-0,14 % -0,005
1-Jahres-Chart
MIMEDX GROUP INC Chart 1 Jahr
5-Tage-Chart
MIMEDX GROUP INC 5-Tage-Chart

Aktuelle News zur MIMEDX Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoIs the Options Market Predicting a Spike in MiMedx Group Stock?2
FrMiMedx launches G4Derm Plus wound care product nationwide1
FrMiMedx Group, Inc: MIMEDX Announces Launch of G4Derm Plus198Flowable Biomimetic Matrix Adds Self-Assembling Peptide Technology to Company's Portfolio G4Derm Plus Added to Premier and Vizient GPO Agreements MARIETTA, Ga., May 08, 2026 (GLOBE NEWSWIRE) -- MiMedx...
► Artikel lesen
30.04.Citizens cuts MiMedx stock price target to $6 on Medicare headwinds1
30.04.Medicare-Gegenwind: Citizens senkt Kursziel für MiMedx auf 6 US-Dollar1
MIMEDX Aktie jetzt für 0€ handeln
30.04.Mimedx expects $260M-$290M 2026 net sales amid $40M cost cuts and wound care reimbursement disruption2
29.04.MiMedx Group, Inc: MIMEDX Announces First Quarter 2026 Operating & Financial Results337Reports First Quarter Net Sales of $59 Million Revises 2026 Net Sales and Adjusted EBITDA Expectations Management to Host Conference Call Today, April 29, 2026, at 4:30 PM ET MARIETTA, Ga.,...
► Artikel lesen
29.04.MIMEDX GROUP, INC. - 8-K, Current Report1
29.04.MIMEDX GROUP, INC. - 10-Q, Quarterly Report9
20.04.Gegenwind im Wundversorgungsgeschäft: Citizens senkt Kursziel für MiMedx15
20.04.Citizens cuts MiMedx stock price target on wound care headwinds2
16.04.MiMedx Expects Approx. $40 Mln Through Restructuring, Eliminates COO Position4
16.04.MiMedx gains on cost reduction initiatives3
16.04.MiMedx Group, Inc: MIMEDX Announces Restructuring and Cost Reduction Initiative159MARIETTA, Ga., April 16, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX" or the "Company") today announced a series of cost reduction initiatives intended to prioritize growth...
► Artikel lesen
16.04.MIMEDX GROUP, INC. - 8-K, Current Report-
23.03.MiMedx Group, Inc: MIMEDX Announces Launch of CHORIOFIX4
05.03.MiMedx Group, Inc: MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX Thyroid Shields231MARIETTA, Ga., March 05, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX" or the "Company") today announced the commercial launch of AMNIOFIX Thyroid Shields, a product line extension...
► Artikel lesen
26.02.MiMedx targets $340M-$360M 2026 revenue while navigating reimbursement changes and boosting surgical growth12
25.02.Earnings Summary: MiMedx Group Q48
25.02.MiMedx Group, Inc: MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results783Net Sales Grew 27% Year-Over-Year for the Fourth Quarter and 20% for the Full Year Fourth Quarter GAAP Net Income and Earnings Per Share were $15 million and $0.10, Respectively Fourth Quarter Adjusted...
► Artikel lesen
Weiter >>
42 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1